Skip to main content
. 2018 Sep 26;10(10):355. doi: 10.3390/cancers10100355

Figure 1.

Figure 1

IL-1R1 abundance predicts response to CTX in patients. Expression analysis of IL-1 receptor in 67 CRC patients treated with CTX. Responsive patients (OR) as well as stable disease (SD) display low amounts of IL-1R1 compared to the non-responsive patients (PD). The differences in IL-1R1 expression between individual groups (OR/SD/PD) were determined by one-way analysis of variance (ANOVA), followed by Fisher LSD test.